Buprenorphine depot - BioDelivery Sciences International/Evonik

Drug Profile

Buprenorphine depot - BioDelivery Sciences International/Evonik

Alternative Names: Buprenorphine long acting - BioDelivery Sciences International/Evonik; Buprenorphine microparticle depot - BioDelivery Sciences International/Evonik; Sustained release buprenorphine injection - BioDelivery Sciences International

Latest Information Update: 26 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Evonik
  • Developer BioDelivery Sciences International; Evonik
  • Class Cyclopropanes; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Opioid abuse; Pain

Most Recent Events

  • 15 May 2017 US FDA approves IND application for Buprenorphine depot before May 2017
  • 21 Mar 2017 9213197- added Sustained Release Buprenorphine Injection as a synonym, added FE
  • 17 Mar 2017 BioDelivery Sciences International plans a phase I trial for Opioid abuse
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top